Sees Q4 Product Sales approximately $7.6M, up 18% sequentially from $6.5M in Q3 2022, but lower than the $9.7M in Q4 2021, which benefitted from $1.7M in COVID-related sales. Pre-pandemic Q4 2019 Product Sales were $6.6M. Sees Core – non-COVID-19 – Product Sales in Q4 2022 approximately $7.6M, vs. approximately $8.0; in Q4 2021. On a constant currency basis, core Q4 2022 product sales would have been $8.5M, a 6% increase over $8.0M in Q4 2021.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on CTSO:
